Reply to “The SARS-COV Pandemic Does Not Absolve From Solid Medical Trade”

REFERENCES

1. 1.↵
   1. Okor I,
   2. Sleem A,
   3. Zhang A,
   4. Kadakia R,
   5. Bob-Manuel T,
   6. Krim SR

   . Suspected COVID-19-induced myopericarditis. Ochsner J. 2021;21(2):181-186. doi: 10.31486/toj.20.0090

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Metlay JP,
   2. Waterer GW,
   3. Long AC,
   4. et al.

   Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45-e67. doi: 10.1164/rccm.201908-1581ST

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Medina de Chazal H,
   2. Del Buono MG,
   3. Keyser-Marcus L

   , et al. Stress cardiomyopathy diagnosis and treatment: JACC state-of-the-art review. J Am Coll Cardiol. 2018;72(16):1955-1971. doi: 10.1016/j.jacc.2018.07.072

   OpenUrlFREE Full Text
4. 4.↵
   1. Kociol RD,
   2. Cooper LT,
   3. Fang JC,
   4. et al.

   Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association. Circulation. 2020;141(6):e69-e92. doi: 10.1161/CIR.0000000000000745

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Imazio M,
   2. Belli R,
   3. Brucato A,
   4. et al.

   Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial. Lancet. 2014;383(9936):2232-2237. doi: 10.1016/S0140-6736(13)62709-9

   OpenUrlCrossRefPubMedWeb of Science